{"id":18432,"date":"2021-01-25T19:35:26","date_gmt":"2021-01-25T19:35:26","guid":{"rendered":"https:\/\/sbpt.org.br\/portal\/?p=18432"},"modified":"2021-01-25T19:35:26","modified_gmt":"2021-01-25T19:35:26","slug":"plano1-vacinacao-covid-19","status":"publish","type":"post","link":"https:\/\/sbpt.org.br\/portal\/plano1-vacinacao-covid-19\/","title":{"rendered":"Portadores de doen\u00e7as pulmonares est\u00e3o entre os grupos priorit\u00e1rios de vacina\u00e7\u00e3o contra a COVID-19"},"content":{"rendered":"<p style=\"text-align: justify\">Pacientes com DPOC, fibrose c\u00edstica, doen\u00e7as intersticiais pulmonares fibrosantes, pneumoconioses, displasia broncopulmonar, hipertens\u00e3o pulmonar e asma grave ter\u00e3o prioridade para receber a vacina da COVID-19 (fase 3).<\/p>\n<p style=\"text-align: justify\">No entanto, \u00e9 necess\u00e1rio aguardar a atualiza\u00e7\u00e3o do Plano Nacional de Imuniza\u00e7\u00e3o (PNI) quanto \u00e0s datas e disponibilidade das vacinas.<\/p>\n<p style=\"text-align: justify\">A primeira vers\u00e3o do <a href=\"https:\/\/d1xe7tfg0uwul9.cloudfront.net\/sbpt-portal\/wp-content\/uploads\/2021\/01\/PlanoVacinac%CC%A7a%CC%83oCovid-v2-22jan2021-nucom.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">documento<\/a> foi divulgada pelo Minist\u00e9rio da Sa\u00fade em 22\/01\/2021.<\/p>\n<p>Outros grupos priorit\u00e1rios s\u00e3o:<\/p>\n<ul style=\"list-style-type: circle\">\n<li style=\"list-style-type: none\">\n<ul style=\"list-style-type: circle\">\n<li>Trabalhadores da \u00e1rea da sa\u00fade (incluindo profissionais da sa\u00fade, profissionais de apoio, cuidadores de idosos, entre outros).<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n<ul style=\"list-style-type: circle\">\n<li style=\"list-style-type: none\">\n<ul>\n<li style=\"text-align: justify\">Povos ind\u00edgenas aldeados.<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n<ul>\n<li style=\"list-style-type: none\">\n<ul>\n<li style=\"text-align: justify\">Comunidades tradicionais ribeirinhas e quilombolas.<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n<ul>\n<li style=\"list-style-type: none\">\n<ul>\n<li style=\"text-align: justify\">Pessoas com defici\u00eancia.<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n<ul>\n<li style=\"list-style-type: none\">\n<ul>\n<li style=\"text-align: justify\">Popula\u00e7\u00e3o em situa\u00e7\u00e3o de rua.<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n<ul>\n<li style=\"list-style-type: none\">\n<ul>\n<li style=\"text-align: justify\">Pessoas com comorbidades.<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n<ul>\n<li style=\"list-style-type: none\">\n<ul>\n<li style=\"text-align: justify\">Trabalhadores da educa\u00e7\u00e3o.<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n<ul>\n<li style=\"list-style-type: none\">\n<ul>\n<li style=\"text-align: justify\">Membros das for\u00e7as de seguran\u00e7a e salvamento.<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n<ul>\n<li style=\"list-style-type: none\">\n<ul>\n<li style=\"text-align: justify\">Funcion\u00e1rios e popula\u00e7\u00e3o do sistema de priva\u00e7\u00e3o de liberdade.<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n<ul>\n<li style=\"list-style-type: none\">\n<ul>\n<li style=\"text-align: justify\">Trabalhadores do transporte coletivo terrestre e a\u00e9reo e transportadores rodovi\u00e1rios de carga.<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n<p style=\"text-align: center\"><a href=\"https:\/\/d1xe7tfg0uwul9.cloudfront.net\/sbpt-portal\/wp-content\/uploads\/2021\/01\/PlanoVacinac\u0327a\u0303oCovid-v2-22jan2021-nucom.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">Saiba mais: Plano Nacional de Operacionaliza\u00e7\u00e3o da Vacina\u00e7\u00e3o Contra a COVID-19.<\/a><\/p>\n<p style=\"text-align: justify\">Para manter-se informado e guardar o registro da vacina, o Minist\u00e9rio da Sa\u00fade orienta fazer download do aplicativo <a href=\"https:\/\/conectesus-paciente.saude.gov.br\/\" target=\"_blank\" rel=\"noopener noreferrer\">Conecte-SUS<\/a>, que tamb\u00e9m alertar\u00e1 para a data para segunda dose.<\/p>\n<!-- AddThis Advanced Settings generic via filter on the_content --><!-- AddThis Share Buttons generic via filter on the_content -->","protected":false},"excerpt":{"rendered":"<p>Pacientes com DPOC, fibrose c\u00edstica, doen\u00e7as intersticiais pulmonares fibrosantes, pneumoconioses, displasia broncopulmonar, hipertens\u00e3o pulmonar e asma grave ter\u00e3o prioridade para receber a vacina da COVID-19 (fase 3). No entanto, \u00e9 necess\u00e1rio aguardar a atualiza\u00e7\u00e3o do Plano Nacional de Imuniza\u00e7\u00e3o (PNI) quanto \u00e0s datas e disponibilidade das vacinas. A primeira vers\u00e3o do documento foi divulgada pelo [&hellip;]<!-- AddThis Advanced Settings generic via filter on get_the_excerpt --><!-- AddThis Share Buttons generic via filter on get_the_excerpt --><\/p>\n","protected":false},"author":3,"featured_media":18433,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"ngg_post_thumbnail":0,"footnotes":""},"categories":[68],"tags":[118,110,316],"class_list":["post-18432","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-noticias","tag-covid-19","tag-ministerio-da-saude","tag-vacina"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v28.6 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Portadores de doen\u00e7as pulmonares est\u00e3o entre os grupos priorit\u00e1rios de vacina\u00e7\u00e3o contra a COVID-19<\/title>\n<meta name=\"description\" content=\"Pacientes com DPOC, fibrose c\u00edstica, fibroses pulmonares, pneumoconioses, displasia broncopulmonar, hipertens\u00e3o pulmonar e asma grave ter\u00e3o prioridade para receber a vacina da COVID-19 (fase 3).\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/sbpt.org.br\/portal\/plano1-vacinacao-covid-19\/\" \/>\n<meta property=\"og:locale\" content=\"pt_BR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Portadores de doen\u00e7as pulmonares est\u00e3o entre os grupos priorit\u00e1rios de vacina\u00e7\u00e3o contra a COVID-19\" \/>\n<meta property=\"og:description\" content=\"Pacientes com DPOC, fibrose c\u00edstica, fibroses pulmonares, pneumoconioses, displasia broncopulmonar, hipertens\u00e3o pulmonar e asma grave ter\u00e3o prioridade para receber a vacina da COVID-19 (fase 3).\" \/>\n<meta property=\"og:url\" content=\"https:\/\/sbpt.org.br\/portal\/plano1-vacinacao-covid-19\/\" \/>\n<meta property=\"og:site_name\" content=\"sbpt.org.br\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/pneumosbpt\" \/>\n<meta property=\"article:published_time\" content=\"2021-01-25T19:35:26+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/sbpt.org.br\/portal\/wp-content\/uploads\/2021\/01\/vacina-ms.png\" \/>\n\t<meta property=\"og:image:width\" content=\"350\" \/>\n\t<meta property=\"og:image:height\" content=\"255\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"Comunica\u00e7\u00e3o SBPT\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@pneumosbpt\" \/>\n<meta name=\"twitter:site\" content=\"@pneumosbpt\" \/>\n<meta name=\"twitter:label1\" content=\"Escrito por\" \/>\n\t<meta name=\"twitter:data1\" content=\"Comunica\u00e7\u00e3o SBPT\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. tempo de leitura\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minuto\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/sbpt.org.br\\\/portal\\\/plano1-vacinacao-covid-19\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/sbpt.org.br\\\/portal\\\/plano1-vacinacao-covid-19\\\/\"},\"author\":{\"name\":\"Comunica\u00e7\u00e3o SBPT\",\"@id\":\"https:\\\/\\\/sbpt.org.br\\\/portal\\\/#\\\/schema\\\/person\\\/adba7f33cf32721354590c6f0eb852d4\"},\"headline\":\"Portadores de doen\u00e7as pulmonares est\u00e3o entre os grupos priorit\u00e1rios de vacina\u00e7\u00e3o contra a COVID-19\",\"datePublished\":\"2021-01-25T19:35:26+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/sbpt.org.br\\\/portal\\\/plano1-vacinacao-covid-19\\\/\"},\"wordCount\":216,\"publisher\":{\"@id\":\"https:\\\/\\\/sbpt.org.br\\\/portal\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/sbpt.org.br\\\/portal\\\/plano1-vacinacao-covid-19\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/sbpt.org.br\\\/portal\\\/wp-content\\\/uploads\\\/2021\\\/01\\\/vacina-ms.png\",\"keywords\":[\"COVID-19\",\"minist\u00e9rio da sa\u00fade\",\"vacina\"],\"articleSection\":[\"Not\u00edcias\"],\"inLanguage\":\"pt-BR\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/sbpt.org.br\\\/portal\\\/plano1-vacinacao-covid-19\\\/\",\"url\":\"https:\\\/\\\/sbpt.org.br\\\/portal\\\/plano1-vacinacao-covid-19\\\/\",\"name\":\"Portadores de doen\u00e7as pulmonares est\u00e3o entre os grupos priorit\u00e1rios de vacina\u00e7\u00e3o contra a COVID-19\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/sbpt.org.br\\\/portal\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/sbpt.org.br\\\/portal\\\/plano1-vacinacao-covid-19\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/sbpt.org.br\\\/portal\\\/plano1-vacinacao-covid-19\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/sbpt.org.br\\\/portal\\\/wp-content\\\/uploads\\\/2021\\\/01\\\/vacina-ms.png\",\"datePublished\":\"2021-01-25T19:35:26+00:00\",\"description\":\"Pacientes com DPOC, fibrose c\u00edstica, fibroses pulmonares, pneumoconioses, displasia broncopulmonar, hipertens\u00e3o pulmonar e asma grave ter\u00e3o prioridade para receber a vacina da COVID-19 (fase 3).\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/sbpt.org.br\\\/portal\\\/plano1-vacinacao-covid-19\\\/#breadcrumb\"},\"inLanguage\":\"pt-BR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/sbpt.org.br\\\/portal\\\/plano1-vacinacao-covid-19\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"pt-BR\",\"@id\":\"https:\\\/\\\/sbpt.org.br\\\/portal\\\/plano1-vacinacao-covid-19\\\/#primaryimage\",\"url\":\"https:\\\/\\\/sbpt.org.br\\\/portal\\\/wp-content\\\/uploads\\\/2021\\\/01\\\/vacina-ms.png\",\"contentUrl\":\"https:\\\/\\\/sbpt.org.br\\\/portal\\\/wp-content\\\/uploads\\\/2021\\\/01\\\/vacina-ms.png\",\"width\":350,\"height\":255},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/sbpt.org.br\\\/portal\\\/plano1-vacinacao-covid-19\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/sbpt.org.br\\\/portal\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Portadores de doen\u00e7as pulmonares est\u00e3o entre os grupos priorit\u00e1rios de vacina\u00e7\u00e3o contra a COVID-19\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/sbpt.org.br\\\/portal\\\/#website\",\"url\":\"https:\\\/\\\/sbpt.org.br\\\/portal\\\/\",\"name\":\"sbpt.org.br\",\"description\":\"Sociedade Brasileira de Pneumologia e Tisiologia\",\"publisher\":{\"@id\":\"https:\\\/\\\/sbpt.org.br\\\/portal\\\/#organization\"},\"alternateName\":\"SBPT\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/sbpt.org.br\\\/portal\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"pt-BR\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/sbpt.org.br\\\/portal\\\/#organization\",\"name\":\"sbpt.org.br\",\"url\":\"https:\\\/\\\/sbpt.org.br\\\/portal\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"pt-BR\",\"@id\":\"https:\\\/\\\/sbpt.org.br\\\/portal\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/sbpt.org.br\\\/portal\\\/wp-content\\\/uploads\\\/2026\\\/10\\\/logo-sbpt.png\",\"contentUrl\":\"https:\\\/\\\/sbpt.org.br\\\/portal\\\/wp-content\\\/uploads\\\/2026\\\/10\\\/logo-sbpt.png\",\"width\":512,\"height\":512,\"caption\":\"sbpt.org.br\"},\"image\":{\"@id\":\"https:\\\/\\\/sbpt.org.br\\\/portal\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/pneumosbpt\",\"https:\\\/\\\/x.com\\\/pneumosbpt\",\"https:\\\/\\\/www.linkedin.com\\\/company\\\/pneumosbpt\\\/\",\"https:\\\/\\\/www.instagram.com\\\/pneumosbpt\\\/\",\"https:\\\/\\\/www.youtube.com\\\/user\\\/socbraspneumol\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/sbpt.org.br\\\/portal\\\/#\\\/schema\\\/person\\\/adba7f33cf32721354590c6f0eb852d4\",\"name\":\"Comunica\u00e7\u00e3o SBPT\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"pt-BR\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/83068fab2f784f5c487104783a7006fb40e8fd85adc44189ac928b9e39fddad8?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/83068fab2f784f5c487104783a7006fb40e8fd85adc44189ac928b9e39fddad8?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/83068fab2f784f5c487104783a7006fb40e8fd85adc44189ac928b9e39fddad8?s=96&d=mm&r=g\",\"caption\":\"Comunica\u00e7\u00e3o SBPT\"},\"url\":\"https:\\\/\\\/sbpt.org.br\\\/portal\\\/author\\\/anahelena\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Portadores de doen\u00e7as pulmonares est\u00e3o entre os grupos priorit\u00e1rios de vacina\u00e7\u00e3o contra a COVID-19","description":"Pacientes com DPOC, fibrose c\u00edstica, fibroses pulmonares, pneumoconioses, displasia broncopulmonar, hipertens\u00e3o pulmonar e asma grave ter\u00e3o prioridade para receber a vacina da COVID-19 (fase 3).","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/sbpt.org.br\/portal\/plano1-vacinacao-covid-19\/","og_locale":"pt_BR","og_type":"article","og_title":"Portadores de doen\u00e7as pulmonares est\u00e3o entre os grupos priorit\u00e1rios de vacina\u00e7\u00e3o contra a COVID-19","og_description":"Pacientes com DPOC, fibrose c\u00edstica, fibroses pulmonares, pneumoconioses, displasia broncopulmonar, hipertens\u00e3o pulmonar e asma grave ter\u00e3o prioridade para receber a vacina da COVID-19 (fase 3).","og_url":"https:\/\/sbpt.org.br\/portal\/plano1-vacinacao-covid-19\/","og_site_name":"sbpt.org.br","article_publisher":"https:\/\/www.facebook.com\/pneumosbpt","article_published_time":"2021-01-25T19:35:26+00:00","og_image":[{"width":350,"height":255,"url":"https:\/\/sbpt.org.br\/portal\/wp-content\/uploads\/2021\/01\/vacina-ms.png","type":"image\/png"}],"author":"Comunica\u00e7\u00e3o SBPT","twitter_card":"summary_large_image","twitter_creator":"@pneumosbpt","twitter_site":"@pneumosbpt","twitter_misc":{"Escrito por":"Comunica\u00e7\u00e3o SBPT","Est. tempo de leitura":"1 minuto"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/sbpt.org.br\/portal\/plano1-vacinacao-covid-19\/#article","isPartOf":{"@id":"https:\/\/sbpt.org.br\/portal\/plano1-vacinacao-covid-19\/"},"author":{"name":"Comunica\u00e7\u00e3o SBPT","@id":"https:\/\/sbpt.org.br\/portal\/#\/schema\/person\/adba7f33cf32721354590c6f0eb852d4"},"headline":"Portadores de doen\u00e7as pulmonares est\u00e3o entre os grupos priorit\u00e1rios de vacina\u00e7\u00e3o contra a COVID-19","datePublished":"2021-01-25T19:35:26+00:00","mainEntityOfPage":{"@id":"https:\/\/sbpt.org.br\/portal\/plano1-vacinacao-covid-19\/"},"wordCount":216,"publisher":{"@id":"https:\/\/sbpt.org.br\/portal\/#organization"},"image":{"@id":"https:\/\/sbpt.org.br\/portal\/plano1-vacinacao-covid-19\/#primaryimage"},"thumbnailUrl":"https:\/\/sbpt.org.br\/portal\/wp-content\/uploads\/2021\/01\/vacina-ms.png","keywords":["COVID-19","minist\u00e9rio da sa\u00fade","vacina"],"articleSection":["Not\u00edcias"],"inLanguage":"pt-BR"},{"@type":"WebPage","@id":"https:\/\/sbpt.org.br\/portal\/plano1-vacinacao-covid-19\/","url":"https:\/\/sbpt.org.br\/portal\/plano1-vacinacao-covid-19\/","name":"Portadores de doen\u00e7as pulmonares est\u00e3o entre os grupos priorit\u00e1rios de vacina\u00e7\u00e3o contra a COVID-19","isPartOf":{"@id":"https:\/\/sbpt.org.br\/portal\/#website"},"primaryImageOfPage":{"@id":"https:\/\/sbpt.org.br\/portal\/plano1-vacinacao-covid-19\/#primaryimage"},"image":{"@id":"https:\/\/sbpt.org.br\/portal\/plano1-vacinacao-covid-19\/#primaryimage"},"thumbnailUrl":"https:\/\/sbpt.org.br\/portal\/wp-content\/uploads\/2021\/01\/vacina-ms.png","datePublished":"2021-01-25T19:35:26+00:00","description":"Pacientes com DPOC, fibrose c\u00edstica, fibroses pulmonares, pneumoconioses, displasia broncopulmonar, hipertens\u00e3o pulmonar e asma grave ter\u00e3o prioridade para receber a vacina da COVID-19 (fase 3).","breadcrumb":{"@id":"https:\/\/sbpt.org.br\/portal\/plano1-vacinacao-covid-19\/#breadcrumb"},"inLanguage":"pt-BR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/sbpt.org.br\/portal\/plano1-vacinacao-covid-19\/"]}]},{"@type":"ImageObject","inLanguage":"pt-BR","@id":"https:\/\/sbpt.org.br\/portal\/plano1-vacinacao-covid-19\/#primaryimage","url":"https:\/\/sbpt.org.br\/portal\/wp-content\/uploads\/2021\/01\/vacina-ms.png","contentUrl":"https:\/\/sbpt.org.br\/portal\/wp-content\/uploads\/2021\/01\/vacina-ms.png","width":350,"height":255},{"@type":"BreadcrumbList","@id":"https:\/\/sbpt.org.br\/portal\/plano1-vacinacao-covid-19\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/sbpt.org.br\/portal\/"},{"@type":"ListItem","position":2,"name":"Portadores de doen\u00e7as pulmonares est\u00e3o entre os grupos priorit\u00e1rios de vacina\u00e7\u00e3o contra a COVID-19"}]},{"@type":"WebSite","@id":"https:\/\/sbpt.org.br\/portal\/#website","url":"https:\/\/sbpt.org.br\/portal\/","name":"sbpt.org.br","description":"Sociedade Brasileira de Pneumologia e Tisiologia","publisher":{"@id":"https:\/\/sbpt.org.br\/portal\/#organization"},"alternateName":"SBPT","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/sbpt.org.br\/portal\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"pt-BR"},{"@type":"Organization","@id":"https:\/\/sbpt.org.br\/portal\/#organization","name":"sbpt.org.br","url":"https:\/\/sbpt.org.br\/portal\/","logo":{"@type":"ImageObject","inLanguage":"pt-BR","@id":"https:\/\/sbpt.org.br\/portal\/#\/schema\/logo\/image\/","url":"https:\/\/sbpt.org.br\/portal\/wp-content\/uploads\/2026\/10\/logo-sbpt.png","contentUrl":"https:\/\/sbpt.org.br\/portal\/wp-content\/uploads\/2026\/10\/logo-sbpt.png","width":512,"height":512,"caption":"sbpt.org.br"},"image":{"@id":"https:\/\/sbpt.org.br\/portal\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/pneumosbpt","https:\/\/x.com\/pneumosbpt","https:\/\/www.linkedin.com\/company\/pneumosbpt\/","https:\/\/www.instagram.com\/pneumosbpt\/","https:\/\/www.youtube.com\/user\/socbraspneumol"]},{"@type":"Person","@id":"https:\/\/sbpt.org.br\/portal\/#\/schema\/person\/adba7f33cf32721354590c6f0eb852d4","name":"Comunica\u00e7\u00e3o SBPT","image":{"@type":"ImageObject","inLanguage":"pt-BR","@id":"https:\/\/secure.gravatar.com\/avatar\/83068fab2f784f5c487104783a7006fb40e8fd85adc44189ac928b9e39fddad8?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/83068fab2f784f5c487104783a7006fb40e8fd85adc44189ac928b9e39fddad8?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/83068fab2f784f5c487104783a7006fb40e8fd85adc44189ac928b9e39fddad8?s=96&d=mm&r=g","caption":"Comunica\u00e7\u00e3o SBPT"},"url":"https:\/\/sbpt.org.br\/portal\/author\/anahelena\/"}]}},"_links":{"self":[{"href":"https:\/\/sbpt.org.br\/portal\/wp-json\/wp\/v2\/posts\/18432","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/sbpt.org.br\/portal\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/sbpt.org.br\/portal\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/sbpt.org.br\/portal\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/sbpt.org.br\/portal\/wp-json\/wp\/v2\/comments?post=18432"}],"version-history":[{"count":0,"href":"https:\/\/sbpt.org.br\/portal\/wp-json\/wp\/v2\/posts\/18432\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/sbpt.org.br\/portal\/wp-json\/wp\/v2\/media\/18433"}],"wp:attachment":[{"href":"https:\/\/sbpt.org.br\/portal\/wp-json\/wp\/v2\/media?parent=18432"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/sbpt.org.br\/portal\/wp-json\/wp\/v2\/categories?post=18432"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/sbpt.org.br\/portal\/wp-json\/wp\/v2\/tags?post=18432"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}